The onset of the COVID-19 pandemic brought unprecedented disruption to drug development.

The coronavirus pandemic has laid bare the inadequacies of many supply chains when it comes to ensuring the safe, secure and rapid delivery of drugs and other critical supplies in a health crisis.

Before investing in new infrastructure, you must first take a step back. 

No. 1: Retrofit your facility with a high-density automated storage and retrieval system.

Today's automated systems can operate 25 years or longer. These are the primary factors to consider.

Paul Dickson, president of wholesale pharmaceutical distributor Morris & Dickson Co. LLC, describes efforts to allocate limited supplies of the antiviral drug remdesivir during the coronavirus pandemic.

The path to success lies in staying ahead of the curve and implementing solutions that make a difference.